Cargando…
Effect of aliskiren on cardiovascular outcomes in patients with prehypertension: a meta-analysis of randomized controlled trials
BACKGROUND: Aliskiren is a widely used therapy for patients with hypertension, however, the effect of aliskiren on major cardiovascular outcomes is a matter of debate. The aim of this study is to evaluate the effects of aliskiren therapy on major cardiovascular outcomes by this meta-analysis of rand...
Autores principales: | Zhang, Jing-Tao, Chen, Ke-Ping, Guan, Ting, Zhang, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396461/ https://www.ncbi.nlm.nih.gov/pubmed/25897206 http://dx.doi.org/10.2147/DDDT.S75111 |
Ejemplares similares
-
Aliskiren for heart failure: a systematic review and meta-analysis of randomized controlled trials
por: Liu, Hongzhi, et al.
Publicado: (2017) -
Aliskiren and Amlodipine in the Management of Essential Hypertension: Meta-Analysis of Randomized Controlled Trials
por: Liu, Yukai, et al.
Publicado: (2013) -
Prehypertension and incidence of cardiovascular disease: a meta-analysis
por: Huang, Yuli, et al.
Publicado: (2013) -
Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008) -
Aliskiren therapy in hypertension and cardiovascular disease: a systematic review and a meta-analysis
por: Fu, Shufang, et al.
Publicado: (2017)